placebo: be used in double-blind drug test

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents effect
Weight: 0.53
, thing
Weight: 0.50
, act
Weight: 0.48
, band
Weight: 0.48
, drug
Weight: 0.47
Siblings vancomycin
Weight: 0.33
, ibuprofen
Weight: 0.32
, bupropion
Weight: 0.32
, warfarin
Weight: 0.32
, metronidazole
Weight: 0.32

Related properties

Property Similarity
be used in double-blind drug test 1.00
be used in drug test 1.00
be used in drug trials 0.88
be used in trials 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Salient implies Plausible

0.27
Rule weight: 0.28
Evidence weight: 0.94
Similarity weight: 1.00
Evidence: 0.94
Plausible(placebo, be used in double-blind drug test)
Evidence: 0.99
¬ Salient(placebo, be used in double-blind drug test)

Similarity expansion

0.85
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 1.00
Evidence: 0.99
Salient(placebo, be used in double-blind drug test)
Evidence: 0.82
¬ Salient(placebo, be used in drug test)
0.84
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 1.00
Evidence: 0.97
Typical(placebo, be used in double-blind drug test)
Evidence: 0.68
¬ Typical(placebo, be used in drug test)
0.82
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 1.00
Evidence: 0.94
Plausible(placebo, be used in double-blind drug test)
Evidence: 0.70
¬ Plausible(placebo, be used in drug test)
0.74
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.88
Evidence: 0.99
Salient(placebo, be used in double-blind drug test)
Evidence: 0.85
¬ Salient(placebo, be used in drug trials)
0.73
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.88
Evidence: 0.97
Typical(placebo, be used in double-blind drug test)
Evidence: 0.82
¬ Typical(placebo, be used in drug trials)
0.71
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.88
Evidence: 0.94
Plausible(placebo, be used in double-blind drug test)
Evidence: 0.79
¬ Plausible(placebo, be used in drug trials)
0.64
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 1.00
Evidence: 0.66
Remarkable(placebo, be used in double-blind drug test)
Evidence: 0.74
¬ Remarkable(placebo, be used in drug test)
0.64
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.75
Evidence: 0.99
Salient(placebo, be used in double-blind drug test)
Evidence: 0.74
¬ Salient(placebo, be used in trials)
0.63
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.75
Evidence: 0.97
Typical(placebo, be used in double-blind drug test)
Evidence: 0.45
¬ Typical(placebo, be used in trials)
0.61
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.75
Evidence: 0.94
Plausible(placebo, be used in double-blind drug test)
Evidence: 0.92
¬ Plausible(placebo, be used in trials)
0.59
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.88
Evidence: 0.66
Remarkable(placebo, be used in double-blind drug test)
Evidence: 0.62
¬ Remarkable(placebo, be used in drug trials)
0.48
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.75
Evidence: 0.66
Remarkable(placebo, be used in double-blind drug test)
Evidence: 0.76
¬ Remarkable(placebo, be used in trials)

Typical and Remarkable implies Salient

0.14
Rule weight: 0.14
Evidence weight: 0.99
Similarity weight: 1.00
Evidence: 0.99
Salient(placebo, be used in double-blind drug test)
Evidence: 0.97
¬ Typical(placebo, be used in double-blind drug test)
Evidence: 0.66
¬ Remarkable(placebo, be used in double-blind drug test)

Typical implies Plausible

0.45
Rule weight: 0.48
Evidence weight: 0.95
Similarity weight: 1.00
Evidence: 0.94
Plausible(placebo, be used in double-blind drug test)
Evidence: 0.97
¬ Typical(placebo, be used in double-blind drug test)